These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2837627)

  • 1. Colchicine does not interfere with the antiphosphaturic effect of 25(OH) vitamin D3 in the rat.
    Friedlaender MM; Wald H; Kopolovic J; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(2-3):103-9. PubMed ID: 2837627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 25-Hydroxycholecalciferol and 1,25-dihydroxycholecalciferol enhances phosphaturia in rats with reduced renal mass: evidence for a PTH-dependent mechanism.
    Rubinger D; Wald H; Popovtzer MM
    Miner Electrolyte Metab; 1990; 16(6):348-54. PubMed ID: 1965220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group.
    Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM
    Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo and in vitro effect of calmodulin antagonists on the renal actions of 25(OH) vitamin D3 in the rat.
    Friedlaender MM; Darmon D; Wald H; Popovtzer MM
    Pflugers Arch; 1989 Dec; 415(3):372-80. PubMed ID: 2560171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the renal tubular effects of vitamin D by cycloheximide in the rat.
    Brezis M; Wald H; Shilo R; Popovtzer MM
    Pflugers Arch; 1983 Aug; 398(3):247-52. PubMed ID: 6688870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal handling of phosphate during extracellular volume expansion and parathyroid hormone administration.
    Rubinger D; Popovtzer MM
    Miner Electrolyte Metab; 1987; 13(5):323-32. PubMed ID: 3670228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 25(OH)vitamin D3 on urinary excretion of cyclic adenosine monophosphate.
    Popovtzer MM; Robinette JB
    Am J Physiol; 1975 Oct; 229(4):907-10. PubMed ID: 171964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jejunal phosphate transport is not regulated by the PTH-adenylate cyclase system. Further studies on the contrasting features between intestinal and renal phosphate transport mechanisms.
    Lee DB; Walling MW; Palant CE; Tallos E
    Miner Electrolyte Metab; 1986; 12(5-6):293-7. PubMed ID: 3027518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for interference of 25(OH)vitamin D3 with phosphaturic action of glucagon.
    Popovtzer MM; Wald H
    Am J Physiol; 1981 Apr; 240(4):F269-75. PubMed ID: 7223886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
    Madsen S; Olgaard K
    Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 1,25-dihydroxyvitamin D3 on intestinal phosphate absorption in rats with a normal vitamin D supply.
    Rizzoli R; Fleisch H; Bonjour JP
    J Clin Invest; 1977 Sep; 60(3):639-47. PubMed ID: 893667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
    Magliola L; Anast CS; Forte LR
    Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D reduces renal NaPi-2 in PTH-infused rats: complexity of vitamin D action on renal P(i) handling.
    Friedlaender MM; Wald H; Dranitzki-Elhalel M; Zajicek HK; Levi M; Popovtzer MM
    Am J Physiol Renal Physiol; 2001 Sep; 281(3):F428-33. PubMed ID: 11502592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of colchicine on urinary phosphate and regulation by parathyroid hormone.
    Dousa TP; Duarte CG; Knox FG
    Am J Physiol; 1976 Jul; 231(1):61-5. PubMed ID: 183512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for interference of 25 (OH) vitamin D3 with phosphaturic action of calcitonin.
    Popovtzer MM; Blum MS; Flis RS
    Am J Physiol; 1977 May; 232(5):E515-21. PubMed ID: 193407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of parathyroid hormone (PTH) and 24,25-dihydroxy-vitamin D3 on adenylyl cyclase of iliac crest biopsies: diagnostic and prognostic tool for evaluation and treatment of uremic patients.
    Gordeladze JO; Mortensen B; Nordal K; Halse J; Dahl E; Aksnes L; Gautvik KM
    Scand J Clin Lab Invest Suppl; 1987; 186():13-20. PubMed ID: 3496656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of divalent ions on basal and hormone-activated renal adenylate cyclase/cyclic AMP system.
    Wald H; Popovtzer MM
    Miner Electrolyte Metab; 1984; 10(2):133-40. PubMed ID: 6321938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphosphaturic action of 25 (OH) vitamin D3 in experimental Fanconi syndrome.
    Popovtzer MM; Mehandru SK; Saghafi D; Blum MS
    Am J Physiol; 1979 Feb; 236(2):E90-7. PubMed ID: 217276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.